EYEGATE PHARMACEUTICALS INC's ticker is EYEGW and the CUSIP is 30233M115. A total of 5 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,000 | -62.3% | 133,097 | -12.0% | 0.00% | -66.7% |
| Q4 2016 | $53,000 | 0.0% | 151,273 | -1.0% | 0.00% | +50.0% |
| Q3 2016 | $53,000 | +960.0% | 152,773 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -95.7% | 152,773 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $115,000 | -3.4% | 152,773 | -3.5% | 0.01% | -12.5% |
| Q4 2015 | $119,000 | +395.8% | 158,273 | +467.8% | 0.01% | +700.0% |
| Q3 2015 | $24,000 | – | 27,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 137,092 | $7,000 | 0.00% |
| CVI Holdings, LLC | 12,900 | $0 | 0.00% |
| UBS Group AG | 4,300 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |